Dermorphin gene sequence peptide with high affinity and selectivity for delta-opioid receptors

Area of Science:

• Biochemistry
• Pharmacology
• Neuroscience

Background:

• Frog skin secretions are a source of biologically active peptides.
• Opioid receptors (mu and delta) are critical targets for pain management and other therapeutic applications.
• Selective ligands for opioid receptors are valuable tools for research and drug development.

Purpose of the Study:

• To investigate the opioid receptor binding characteristics of dermorphin gene-associated peptide (DGAP) and its analogs.
• To determine the selectivity of DGAP and its derivatives for mu- and delta-opioid receptors.
• To explore the potential of these peptides in the design of novel opioid receptor agonists and antagonists.

Main Methods:

• Isolation and synthesis of DGAP and its analog [D-Met2]DGAP from frog skin cDNA.
• In vitro opioid receptor binding assays using rat brain synaptosomes.
• Determination of IC50 values and selectivity ratios (SR) for mu- and delta-opioid receptors.

Main Results:

• DGAP demonstrated moderate affinity for mu- and delta-opioid receptors.
• [D-Met2]DGAP exhibited very high affinity and selectivity for delta-opioid receptors (SR = 1345).
• Dermorphin was confirmed as a selective mu-opioid receptor ligand.

Conclusions:

• Frog skin cDNA encodes peptides with significant opioid receptor activity.
• [D-Met2]DGAP represents one of the most selective delta-opioid receptor ligands reported.
• These findings provide valuable insights for the rational design of future opioid receptor-targeting drugs.